Patients recently diagnosed with cancer show an increased risk for major bleeding after myocardial infarction, with the risk ...

In patients undergoing revascularization for left main coronary artery disease, CABG is associated with higher rates of all bleeds and in-hospital major bleeding, while PCI is linked to more ...

A consensus statement from two European cardiology organizations contends antithrombotic treatment for myocardial infarction and angina overlooks sex differences that heighten bleeding risk in women.

Abelacimab shows a 62% reduction in major or clinically relevant non-major bleeding compared to rivaroxaban in AFib patients. The study highlights an 89% reduction in gastrointestinal bleeding, a ...

WASHINGTON, DC—For patients who present with STEMI complicated by cardiogenic shock (STEMI-CS), it’s not news that the long-awaited DanGer Shock trial showed better 180-day survival after Impella CP ...